Victory Capital Management Inc. grew its stake in shares of CME Group Inc (NASDAQ:CME) by 189.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 98,067 shares of the financial services provider’s stock after buying an additional 64,233 shares during the period. Victory Capital Management Inc.’s holdings in CME Group were worth $16,140,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Resources Investment Advisors Inc. increased its position in shares of CME Group by 2,800.0% in the fourth quarter. Resources Investment Advisors Inc. now owns 145 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 140 shares during the last quarter. Ruggie Capital Group bought a new position in shares of CME Group in the fourth quarter worth approximately $28,000. Smith Asset Management Group LP increased its position in shares of CME Group by 200.0% in the fourth quarter. Smith Asset Management Group LP now owns 150 shares of the financial services provider’s stock worth $28,000 after purchasing an additional 100 shares during the last quarter. Dubuque Bank & Trust Co. increased its position in shares of CME Group by 83.1% in the first quarter. Dubuque Bank & Trust Co. now owns 152 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 69 shares during the last quarter. Finally, Nelson Roberts Investment Advisors LLC bought a new position in shares of CME Group in the fourth quarter worth approximately $33,000. Hedge funds and other institutional investors own 84.78% of the company’s stock.
In other CME Group news, insider Kathleen M. Cronin sold 8,340 shares of the stock in a transaction on Thursday, March 14th. The stock was sold at an average price of $167.54, for a total value of $1,397,283.60. Following the completion of the transaction, the insider now owns 41,604 shares in the company, valued at $6,970,334.16. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Charles P. Carey sold 10,000 shares of the stock in a transaction on Wednesday, May 8th. The stock was sold at an average price of $179.02, for a total value of $1,790,200.00. Following the completion of the transaction, the director now owns 37,799 shares of the company’s stock, valued at approximately $6,766,776.98. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 38,489 shares of company stock valued at $6,739,196. 1.20% of the stock is owned by corporate insiders.
CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, May 1st. The financial services provider reported $1.62 EPS for the quarter, beating analysts’ consensus estimates of $1.60 by $0.02. The company had revenue of $1.18 billion during the quarter, compared to the consensus estimate of $1.19 billion. CME Group had a return on equity of 9.29% and a net margin of 42.47%. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.86 earnings per share. Research analysts predict that CME Group Inc will post 6.62 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Monday, June 10th will be issued a dividend of $0.75 per share. The ex-dividend date of this dividend is Friday, June 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.62%. CME Group’s dividend payout ratio is presently 43.99%.
Several brokerages have issued reports on CME. Citigroup set a $205.00 target price on CME Group and gave the stock a “buy” rating in a research note on Friday, February 15th. BidaskClub lowered CME Group from a “buy” rating to a “hold” rating in a research note on Thursday, January 31st. JPMorgan Chase & Co. began coverage on CME Group in a research note on Friday, February 15th. They issued an “underweight” rating and a $164.00 target price for the company. Zacks Investment Research raised CME Group from a “sell” rating to a “hold” rating in a research note on Wednesday, April 17th. Finally, ValuEngine lowered CME Group from a “buy” rating to a “hold” rating in a research note on Wednesday, March 20th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $189.71.
WARNING: “Victory Capital Management Inc. Has $16.14 Million Stake in CME Group Inc (CME)” was originally published by Baseball Daily News and is the property of of Baseball Daily News. If you are reading this story on another domain, it was copied illegally and republished in violation of US & international trademark & copyright laws. The legal version of this story can be read at https://www.baseballdailydigest.com/news/2019/05/20/victory-capital-management-inc-has-16-14-million-stake-in-cme-group-inc-cme.html.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Featured Story: Why do commodities matter?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.